Report Overview:
The Global Allogeneic Stem Cell Therapy Market Size was estimated at USD 829.93 million in 2023 and is projected to reach USD 1502.65 million by 2029, exhibiting a CAGR of 10.40% during the forecast period.
This report provides a deep insight into the global Allogeneic Stem Cell Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter?s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Allogeneic Stem Cell Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Allogeneic Stem Cell Therapy market in any manner.
Global Allogeneic Stem Cell Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Escape Therapeutics, Inc.
Lonza Group Ltd.
Osiris Therapeutics (Smith & Nephew)
NuVasive
Chiesi Pharmaceuticals
JCR Pharmaceutical
Pharmicell
Anterogen
MolMed S.p.A.
Takeda (TiGenix)
Market Segmentation (by Type)
Adult Stem Cell Therapy
Human Embryonic Stem Cell Therapy
Induced Pluripotent Stem Cell Therapy
Others
Market Segmentation (by Application)
Musculoskeletal Disorder
Wounds & Injuries
Cardiovascular Diseases
Others
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Allogeneic Stem Cell Therapy Market
? Overview of the regional outlook of the Allogeneic Stem Cell Therapy Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Allogeneic Stem Cell Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Allogeneic Stem Cell Therapy
1.2 Key Market Segments
1.2.1 Allogeneic Stem Cell Therapy Segment by Type
1.2.2 Allogeneic Stem Cell Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Allogeneic Stem Cell Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Allogeneic Stem Cell Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Allogeneic Stem Cell Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Allogeneic Stem Cell Therapy Market Competitive Landscape
3.1 Global Allogeneic Stem Cell Therapy Sales by Manufacturers (2019-2024)
3.2 Global Allogeneic Stem Cell Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Allogeneic Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Allogeneic Stem Cell Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Allogeneic Stem Cell Therapy Sales Sites, Area Served, Product Type
3.6 Allogeneic Stem Cell Therapy Market Competitive Situation and Trends
3.6.1 Allogeneic Stem Cell Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Allogeneic Stem Cell Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Allogeneic Stem Cell Therapy Industry Chain Analysis
4.1 Allogeneic Stem Cell Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Allogeneic Stem Cell Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Allogeneic Stem Cell Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Allogeneic Stem Cell Therapy Sales Market Share by Type (2019-2024)
6.3 Global Allogeneic Stem Cell Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Allogeneic Stem Cell Therapy Price by Type (2019-2024)
7 Allogeneic Stem Cell Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Allogeneic Stem Cell Therapy Market Sales by Application (2019-2024)
7.3 Global Allogeneic Stem Cell Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Allogeneic Stem Cell Therapy Sales Growth Rate by Application (2019-2024)
8 Allogeneic Stem Cell Therapy Market Segmentation by Region
8.1 Global Allogeneic Stem Cell Therapy Sales by Region
8.1.1 Global Allogeneic Stem Cell Therapy Sales by Region
8.1.2 Global Allogeneic Stem Cell Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Allogeneic Stem Cell Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Allogeneic Stem Cell Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Allogeneic Stem Cell Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Allogeneic Stem Cell Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Allogeneic Stem Cell Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Escape Therapeutics, Inc.
9.1.1 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Basic Information
9.1.2 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Product Overview
9.1.3 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Product Market Performance
9.1.4 Escape Therapeutics, Inc. Business Overview
9.1.5 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy SWOT Analysis
9.1.6 Escape Therapeutics, Inc. Recent Developments
9.2 Lonza Group Ltd.
9.2.1 Lonza Group Ltd. Allogeneic Stem Cell Therapy Basic Information
9.2.2 Lonza Group Ltd. Allogeneic Stem Cell Therapy Product Overview
9.2.3 Lonza Group Ltd. Allogeneic Stem Cell Therapy Product Market Performance
9.2.4 Lonza Group Ltd. Business Overview
9.2.5 Lonza Group Ltd. Allogeneic Stem Cell Therapy SWOT Analysis
9.2.6 Lonza Group Ltd. Recent Developments
9.3 Osiris Therapeutics (Smith and Nephew)
9.3.1 Osiris Therapeutics (Smith and Nephew) Allogeneic Stem Cell Therapy Basic Information
9.3.2 Osiris Therapeutics (Smith and Nephew) Allogeneic Stem Cell Therapy Product Overview
9.3.3 Osiris Therapeutics (Smith and Nephew) Allogeneic Stem Cell Therapy Product Market Performance
9.3.4 Osiris Therapeutics (Smith and Nephew) Allogeneic Stem Cell Therapy SWOT Analysis
9.3.5 Osiris Therapeutics (Smith and Nephew) Business Overview
9.3.6 Osiris Therapeutics (Smith and Nephew) Recent Developments
9.4 NuVasive
9.4.1 NuVasive Allogeneic Stem Cell Therapy Basic Information
9.4.2 NuVasive Allogeneic Stem Cell Therapy Product Overview
9.4.3 NuVasive Allogeneic Stem Cell Therapy Product Market Performance
9.4.4 NuVasive Business Overview
9.4.5 NuVasive Recent Developments
9.5 Chiesi Pharmaceuticals
9.5.1 Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Basic Information
9.5.2 Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Product Overview
9.5.3 Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Product Market Performance
9.5.4 Chiesi Pharmaceuticals Business Overview
9.5.5 Chiesi Pharmaceuticals Recent Developments
9.6 JCR Pharmaceutical
9.6.1 JCR Pharmaceutical Allogeneic Stem Cell Therapy Basic Information
9.6.2 JCR Pharmaceutical Allogeneic Stem Cell Therapy Product Overview
9.6.3 JCR Pharmaceutical Allogeneic Stem Cell Therapy Product Market Performance
9.6.4 JCR Pharmaceutical Business Overview
9.6.5 JCR Pharmaceutical Recent Developments
9.7 Pharmicell
9.7.1 Pharmicell Allogeneic Stem Cell Therapy Basic Information
9.7.2 Pharmicell Allogeneic Stem Cell Therapy Product Overview
9.7.3 Pharmicell Allogeneic Stem Cell Therapy Product Market Performance
9.7.4 Pharmicell Business Overview
9.7.5 Pharmicell Recent Developments
9.8 Anterogen
9.8.1 Anterogen Allogeneic Stem Cell Therapy Basic Information
9.8.2 Anterogen Allogeneic Stem Cell Therapy Product Overview
9.8.3 Anterogen Allogeneic Stem Cell Therapy Product Market Performance
9.8.4 Anterogen Business Overview
9.8.5 Anterogen Recent Developments
9.9 MolMed S.p.A.
9.9.1 MolMed S.p.A. Allogeneic Stem Cell Therapy Basic Information
9.9.2 MolMed S.p.A. Allogeneic Stem Cell Therapy Product Overview
9.9.3 MolMed S.p.A. Allogeneic Stem Cell Therapy Product Market Performance
9.9.4 MolMed S.p.A. Business Overview
9.9.5 MolMed S.p.A. Recent Developments
9.10 Takeda (TiGenix)
9.10.1 Takeda (TiGenix) Allogeneic Stem Cell Therapy Basic Information
9.10.2 Takeda (TiGenix) Allogeneic Stem Cell Therapy Product Overview
9.10.3 Takeda (TiGenix) Allogeneic Stem Cell Therapy Product Market Performance
9.10.4 Takeda (TiGenix) Business Overview
9.10.5 Takeda (TiGenix) Recent Developments
10 Allogeneic Stem Cell Therapy Market Forecast by Region
10.1 Global Allogeneic Stem Cell Therapy Market Size Forecast
10.2 Global Allogeneic Stem Cell Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Allogeneic Stem Cell Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Allogeneic Stem Cell Therapy Market Size Forecast by Region
10.2.4 South America Allogeneic Stem Cell Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Allogeneic Stem Cell Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Allogeneic Stem Cell Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Allogeneic Stem Cell Therapy by Type (2025-2030)
11.1.2 Global Allogeneic Stem Cell Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Allogeneic Stem Cell Therapy by Type (2025-2030)
11.2 Global Allogeneic Stem Cell Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Allogeneic Stem Cell Therapy Sales (K Units) Forecast by Application
11.2.2 Global Allogeneic Stem Cell Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Allogeneic Stem Cell Therapy Market Size Comparison by Region (M USD)
Table 5. Global Allogeneic Stem Cell Therapy Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Allogeneic Stem Cell Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Allogeneic Stem Cell Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Allogeneic Stem Cell Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allogeneic Stem Cell Therapy as of 2022)
Table 10. Global Market Allogeneic Stem Cell Therapy Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Allogeneic Stem Cell Therapy Sales Sites and Area Served
Table 12. Manufacturers Allogeneic Stem Cell Therapy Product Type
Table 13. Global Allogeneic Stem Cell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Allogeneic Stem Cell Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Allogeneic Stem Cell Therapy Market Challenges
Table 22. Global Allogeneic Stem Cell Therapy Sales by Type (K Units)
Table 23. Global Allogeneic Stem Cell Therapy Market Size by Type (M USD)
Table 24. Global Allogeneic Stem Cell Therapy Sales (K Units) by Type (2019-2024)
Table 25. Global Allogeneic Stem Cell Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Allogeneic Stem Cell Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Allogeneic Stem Cell Therapy Market Size Share by Type (2019-2024)
Table 28. Global Allogeneic Stem Cell Therapy Price (USD/Unit) by Type (2019-2024)
Table 29. Global Allogeneic Stem Cell Therapy Sales (K Units) by Application
Table 30. Global Allogeneic Stem Cell Therapy Market Size by Application
Table 31. Global Allogeneic Stem Cell Therapy Sales by Application (2019-2024) & (K Units)
Table 32. Global Allogeneic Stem Cell Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Allogeneic Stem Cell Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Allogeneic Stem Cell Therapy Market Share by Application (2019-2024)
Table 35. Global Allogeneic Stem Cell Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Allogeneic Stem Cell Therapy Sales by Region (2019-2024) & (K Units)
Table 37. Global Allogeneic Stem Cell Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Allogeneic Stem Cell Therapy Sales by Country (2019-2024) & (K Units)
Table 39. Europe Allogeneic Stem Cell Therapy Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Allogeneic Stem Cell Therapy Sales by Region (2019-2024) & (K Units)
Table 41. South America Allogeneic Stem Cell Therapy Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Allogeneic Stem Cell Therapy Sales by Region (2019-2024) & (K Units)
Table 43. Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Basic Information
Table 44. Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Product Overview
Table 45. Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Escape Therapeutics, Inc. Business Overview
Table 47. Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy SWOT Analysis
Table 48. Escape Therapeutics, Inc. Recent Developments
Table 49. Lonza Group Ltd. Allogeneic Stem Cell Therapy Basic Information
Table 50. Lonza Group Ltd. Allogeneic Stem Cell Therapy Product Overview
Table 51. Lonza Group Ltd. Allogeneic Stem Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Lonza Group Ltd. Business Overview
Table 53. Lonza Group Ltd. Allogeneic Stem Cell Therapy SWOT Analysis
Table 54. Lonza Group Ltd. Recent Developments
Table 55. Osiris Therapeutics (Smith and Nephew) Allogeneic Stem Cell Therapy Basic Information
Table 56. Osiris Therapeutics (Smith and Nephew) Allogeneic Stem Cell Therapy Product Overview
Table 57. Osiris Therapeutics (Smith and Nephew) Allogeneic Stem Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Osiris Therapeutics (Smith and Nephew) Allogeneic Stem Cell Therapy SWOT Analysis
Table 59. Osiris Therapeutics (Smith and Nephew) Business Overview
Table 60. Osiris Therapeutics (Smith and Nephew) Recent Developments
Table 61. NuVasive Allogeneic Stem Cell Therapy Basic Information
Table 62. NuVasive Allogeneic Stem Cell Therapy Product Overview
Table 63. NuVasive Allogeneic Stem Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. NuVasive Business Overview
Table 65. NuVasive Recent Developments
Table 66. Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Basic Information
Table 67. Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Product Overview
Table 68. Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Chiesi Pharmaceuticals Business Overview
Table 70. Chiesi Pharmaceuticals Recent Developments
Table 71. JCR Pharmaceutical Allogeneic Stem Cell Therapy Basic Information
Table 72. JCR Pharmaceutical Allogeneic Stem Cell Therapy Product Overview
Table 73. JCR Pharmaceutical Allogeneic Stem Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. JCR Pharmaceutical Business Overview
Table 75. JCR Pharmaceutical Recent Developments
Table 76. Pharmicell Allogeneic Stem Cell Therapy Basic Information
Table 77. Pharmicell Allogeneic Stem Cell Therapy Product Overview
Table 78. Pharmicell Allogeneic Stem Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Pharmicell Business Overview
Table 80. Pharmicell Recent Developments
Table 81. Anterogen Allogeneic Stem Cell Therapy Basic Information
Table 82. Anterogen Allogeneic Stem Cell Therapy Product Overview
Table 83. Anterogen Allogeneic Stem Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Anterogen Business Overview
Table 85. Anterogen Recent Developments
Table 86. MolMed S.p.A. Allogeneic Stem Cell Therapy Basic Information
Table 87. MolMed S.p.A. Allogeneic Stem Cell Therapy Product Overview
Table 88. MolMed S.p.A. Allogeneic Stem Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. MolMed S.p.A. Business Overview
Table 90. MolMed S.p.A. Recent Developments
Table 91. Takeda (TiGenix) Allogeneic Stem Cell Therapy Basic Information
Table 92. Takeda (TiGenix) Allogeneic Stem Cell Therapy Product Overview
Table 93. Takeda (TiGenix) Allogeneic Stem Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Takeda (TiGenix) Business Overview
Table 95. Takeda (TiGenix) Recent Developments
Table 96. Global Allogeneic Stem Cell Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Allogeneic Stem Cell Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Allogeneic Stem Cell Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Allogeneic Stem Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Allogeneic Stem Cell Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Allogeneic Stem Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Allogeneic Stem Cell Therapy Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Allogeneic Stem Cell Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Allogeneic Stem Cell Therapy Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Allogeneic Stem Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Allogeneic Stem Cell Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Allogeneic Stem Cell Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Allogeneic Stem Cell Therapy Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Allogeneic Stem Cell Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Allogeneic Stem Cell Therapy Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Allogeneic Stem Cell Therapy Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Allogeneic Stem Cell Therapy Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Allogeneic Stem Cell Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Allogeneic Stem Cell Therapy Market Size (M USD), 2019-2030
Figure 5. Global Allogeneic Stem Cell Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Allogeneic Stem Cell Therapy Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Allogeneic Stem Cell Therapy Market Size by Country (M USD)
Figure 11. Allogeneic Stem Cell Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Allogeneic Stem Cell Therapy Revenue Share by Manufacturers in 2023
Figure 13. Allogeneic Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Allogeneic Stem Cell Therapy Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Allogeneic Stem Cell Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Allogeneic Stem Cell Therapy Market Share by Type
Figure 18. Sales Market Share of Allogeneic Stem Cell Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Allogeneic Stem Cell Therapy by Type in 2023
Figure 20. Market Size Share of Allogeneic Stem Cell Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Allogeneic Stem Cell Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Allogeneic Stem Cell Therapy Market Share by Application
Figure 24. Global Allogeneic Stem Cell Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Allogeneic Stem Cell Therapy Sales Market Share by Application in 2023
Figure 26. Global Allogeneic Stem Cell Therapy Market Share by Application (2019-2024)
Figure 27. Global Allogeneic Stem Cell Therapy Market Share by Application in 2023
Figure 28. Global Allogeneic Stem Cell Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Allogeneic Stem Cell Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Allogeneic Stem Cell Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Allogeneic Stem Cell Therapy Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Allogeneic Stem Cell Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Allogeneic Stem Cell Therapy Sales Market Share by Country in 2023
Figure 37. Germany Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Allogeneic Stem Cell Therapy Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Allogeneic Stem Cell Therapy Sales Market Share by Region in 2023
Figure 44. China Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Allogeneic Stem Cell Therapy Sales and Growth Rate (K Units)
Figure 50. South America Allogeneic Stem Cell Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Allogeneic Stem Cell Therapy Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Allogeneic Stem Cell Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Allogeneic Stem Cell Therapy Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Allogeneic Stem Cell Therapy Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Allogeneic Stem Cell Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Allogeneic Stem Cell Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Allogeneic Stem Cell Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Allogeneic Stem Cell Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Allogeneic Stem Cell Therapy Market Share Forecast by Application (2025-2030)
